Ono Pharmaceutical Co. Ltd.

OPHLY | OTC

Price Alert Chart Builder DCF Calculator

$5.25

+$0.10 (+1.94%)

Sep 22, 2026, 9:46 AM ET · Market open

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2026 Mar 30, 2026	FY 2025 Mar 30, 2025	FY 2024 Mar 30, 2024	FY 2023 Mar 30, 2023	FY 2022 Mar 30, 2022	FY 2021 Mar 30, 2021
Revenue	546.89B	486.87B	502.67B	447.19B	361.36B	309.28B
Cost of Revenue	150.26B	147.95B	127.13B	110.06B	93.51B	85.57B
Gross Profit	396.63B	338.92B	375.55B	337.13B	267.85B	223.71B
Operating Income	109.57B	59.75B	163.1B	141.96B	103.2B	98.33B
Interest Income	4.19B	4.77B	4.03B	2.48B	2.71B	2.69B
Pretax Income	98.24B	59.33B	163.73B	143.53B	105.03B	100.89B
Net Income	73.97B	50.05B	127.98B	112.72B	80.52B	75.43B
Selling & General & Admin	131.15B	122.22B	97.39B	86.64B	74.12B	66.62B
Research & Development	155.91B	149.87B	112.38B	95.34B	75.88B	62.38B
Other Expenses	n/a	7.09B	2.68B	13.17B	14.66B	-3.62B
Operating Expenses	287.06B	279.17B	212.44B	195.16B	164.65B	125.38B
Interest Expense	3.75B	5.32B	229M	913M	874M	137M
Selling & Marketing Expenses	n/a	30.65B	24.02B	17.84B	11.5B	6.9B
Cost & Expenses	437.32B	427.12B	339.57B	305.22B	258.17B	210.95B
Income Tax Expense	24.11B	9.16B	35.69B	30.62B	24.34B	25.39B
Shares Outstanding (Basic)	1.41B	1.41B	1.44B	4.4B	4.47B	4.49B
Shares Outstanding (Diluted)	1.41B	1.41B	1.44B	4.4B	4.47B	4.49B
EPS (Basic)	52.73	35.47	88.87	76.94	54.06	50.36
EPS (Diluted)	52.73	35.47	88.87	76.92	54.05	50.36
EBITDA	149.6B	91.54B	178.44B	161.9B	123.62B	116.85B
EBIT	109.57B	64.65B	160.3B	144.45B	105.9B	101.03B
Depreciation & Amortization	40.03B	26.89B	18.14B	17.45B	17.72B	15.82B